References
- 1. Pavlović DM. Neuropsihologija, bihevioralna neurologija i neuropsihijatrija. Beograd: Orion Art, 2012.
- 2. Pavlović DM, Pavlović AM. B Vitamins and Dementias. Curr Top 2013;21(1-2):39-48.
- 3. Nahas R, Balla A. Complementary and alternative medicine for prevention and treatment of the common cold. Can Fam Physician. 2011 Jan;57(1):31-36.
- 4. World Health Organization and Food and Agriculture Organization of the United Nations. Vitamin and mineral requirements in human nutrition. 2nd edition. Geneva: World Health Organization and Food and Agriculture Organization of the United Nations, 2004.
- 5. Harrison FE, May JM. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med. 2009 Mar 15;46(6):719-730.
- 6. Levine M, Padayatty SJ, Espey MG. Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr. 2011 Mar;2(2):78-88.
- 7. Kallner A, Hartmann D, Hornig D. Steady-state turnover and body pool of ascorbic acid in man. American Journal of Clinical Nutrition, 1979, 32:530–539.
- 8. May JM. The SLC23 family of ascorbate transporters: ensuring that you get and keep your daily dose of vitamin C. Br J Pharmacol. 2011 Dec;164(7):1793-801.
- 9. Gess B, Sevimli S, Strecker JK, Young P, Schäbitz WR. Sodium-dependent vitamin C transporter 2 (SVCT2) expression and activity in brain capillary endothelial cells after transient ischemia in mice. PLoS One. 2011 Feb 11;6(2):e17139.
- 10. Gess B, Röhr D, Young P. Ascorbic acid and sodium-dependent vitamin C transporters in the peripheral nervous system: from basic science to clinical trials. Antioxid Redox Signal. 2013 Dec 10;19(17):2105-2114.
- 11. Verhamme C, de Haan RJ, Vermeulen M, Baas F, de Visser M, van Schaik IN. Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial. BMC Med. 2009 Nov 12;7:70.
- 12. Jacob RA. Vitamin C. In: Shils ME, Olson Ja, Shike M, eds. Modern nutrition in health and disease, 8th ed. Philadelphia: Lea and Febiger, 1994; 432-448.
- 13. El-Sokkary GH Awadalla EA. The protective role of vitamin C against cerebral and pulmonary damage induced by cadmium chloride in male adult albino rat. The Open Neuroendocrinology Journal, 2011, 4, 1-8.
- 14. Hampl JS, Taylor CA, Johnston CS: Vitamin C deficiency and depletion in the United States: the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Pub Health 2004, 94:870-875.
- 15. Ramakrishna T. Vitamins and brain development. Physiol Res. 1999;48(3):175-187.
- 16. Rice, M.E., Russo-Menna, I. 1998. Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience 82, 1213-1223.
- 17. Bowman GL, Dodge H, Frei B, Calabrese C, Oken BS, Kaye JA, Quinn JF. Ascorbic acid and rates of cognitive decline in Alzheimer’s disease. J Alzheimers Dis. 2009;16(1):93-8
- 18. Parle M, Dhingra D. Ascorbic Acid: a promising memory-enhancer in mice. J Pharmacol Sci 2003;93:129–135.
- 19. Wang Y, Liu XJ, Robitaille L, Eintracht S, MacNamara E, Hoffer LJ. Effects of vitamin C and vitamin D administration on mood and distress in acutely hospitalized patients. Am J Clin Nutr 2013;98(3):705-11.
- 20. Candelario-Jalil E, Akundi RS, Bhatia HS, Lieb K, Appel K, Muñoz E, Hüll M, Fiebich BL. Ascorbic acid enhances the inhibitory effect of aspirin on neuronal cyclooxygenase-2-mediated prostaglandin E2 production. J Neuroimmunol. 2006 May;174(1-2):39-51.
- 21. Pavlovic DM, Pavlovic AM, Žugić S. Patogeneza Alzheimerove bolesti. Vojnosanit Pregl. 2007 Nov;64(11):765-772.
- 22. Cheng F, Cappai R, Ciccotosto GD, Svensson G, Multhaup G, Fransson LÅ, Mani K. Suppression of amyloid beta A11 antibody immunoreactivity by vitamin C: possible role of heparan sulfate oligosaccharides derived from glypican-1 by ascorbate-induced, nitric oxide (NO)-catalyzed degradation. J Biol Chem. 2011 Aug 5;286(31):27559-72.
- 23. Zandi PP, Anthony JC, Khachaturian AS, Stone SV, Gustafson D, Tschanz JT, Norton MC, Welsh-Bohmer KA, Breitner JC; Cache County Study Group. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol. 2004 Jan;61(1):82-88
- 24. Wengreen HJ, Munger RG, Corcoran CD, Zandi P, Hayden KM, Fotuhi M, et al. Antioxidant intake and cognitive function of elderly men and women: the Cache County Study. J Nutr Health Aging. 2007 May-Jun;11(3):230-237.
- 25. Bowman GL. Ascorbic acid, cognitive function, and Alzheimer’s disease: a current review and future direction. Biofactors. 2012 Mar-Apr;38(2):114-122
- 26. Fotuhi M, Zandi PP, Hayden KM, Khachaturian AS, Szekely CA, Wengreen H, et al. Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache County Study. Alzheimers Dement. 2008 May;4(3):223-227.
- 27. Harrison FE, Hosseini AH, McDonald MP, May JM. Vitamin C reduces spatial learning deficits in middle-aged and very old APP/PSEN1 transgenic and wild-type mice. Pharmacol Biochem Behav. 2009 Oct;93(4):443-450.
- 28. Harrison FE. A critical review of vitamin C for the prevention of age-related cognitive decline and Alzheimer’s disease. J Alzheimers Dis. 2012;29(4):711-726.
- 29. Riordan NH, Riordan HD, Casciari JP. Clinical and experimental experiences with Intravenous Vitamin C. Journal of Orthomolecular Medicine 2000 Vol. 15, No. 4, 201-213.
- 30. Pavlović AM, Pekmezović T, Zidverc-Trajković J, Jovanović Z, Mijajlovic M, Pavlović D, Tomić G, Sternić N. What are the differences between younger and older patients with symptomatic small vessel disease? Clin Neurol Neurosurg. 2011;113(9):762-767.
- 31. Chen GC, Lu DB, Pang Z, Liu QF. Vitamin C intake, circulating vitamin C and risk of stroke: a meta-analysis of prospective studies. J Am Heart Assoc. 2013 Nov 27;2(6):e000329.
- 32. Razmkon A, Sadidi A, Sherafat-Kazemzadeh E, MD, Mehrafshan A, Jamali M, Malekpour B, Saghafinia M. Administration of Vitamin C and Vitamin E in Severe Head Injury: A Randomized Double-blind Controlled Trial. Clinical Neurosurgery 2011; 58, 133-137.
- 33. Pastor P, Cisternas P, Salazar K, Silva-Alvarez C, Oyarce K, Jara N, Espinoza F, Martínez AD, Nualart F. SVCT2 vitamin C transporter expression in progenitor cells of the postnatal neurogenic niche. Front Cell Neurosci. 2013 Aug 13;7:119.
- 34. Ye Z, Song H. Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil 2008;15(1):26-34.
- 35. Food and Drug Administration. Food labeling: Health claims and label statements: Antioxidant vitamins and cancer; final rule. Federal register 1993; 58:2622-2660.
- 36. Thiagarajan R, Manikandan R. Antioxidants and cataract. Free Radic Res. 2013 May;47(5):337-45.
- 37. Miller DR, Hayes KC. Vitamin excess and toxicity. In: Hathcock JN, ed. Nutritional toxicology, vol. 1. New York: Academic Press, 1982; 81-133.
- 38. Bendich A, Langseth L. The health effects of vitamin C supplementation: A review. J am Coll Nutr 1995; 14:124-136.
- 39. Food and Nutrution Board. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press, 2000.
- 40. Pavlović DM, Pavlović AM. Deficit vitamina B12 u neurologiji. Srp arh celok lek 2003;131:412-418.
- 41. Cathcart RF. Vitamin C: the nontoxic, nonrate-limited, antioxidant free radical scavenger. Med Hypotheses 1985;18:61–77.